Page 27 - SFHN0716web_Neat

ADVANCES IN TECHNOLOGY

Proton Therapy Arrives Partnering to Bring Breakthrough
at Miami Cancer Institute
Cancer Care to Miami
(l-r) Brian E. Keeley, Baptist Health president and CEO; Manoj Sahasrabudhe, IBA Chief
Operating Officer; Wayne Brackin, Baptist Health executive vice president and COO; Dr. Robins & Morton is proud to be
a part of the team bringing a
Michael J. Zinner, founding CEO and executive medical director of Miami Cancer breakthrough in cancer care to
Institute; Michele Ryder, R.N., chief operating officer/chief nursing officer of Miami Miami. The revolutionary 220-ton
Cancer Institute; S. Lawrence Kahn III, founding chair of the Miami Cancer Institute proton therapy cyclotron, “Pete”, was
board of directors; Dr. Minesh Mehta, deputy director of the Miami Cancer Institute and recently delivered to Miami Cancer
chief of radiation oncology; Reverend William Chambers III; and Dr. Leonard Kalman, Institute and will provide next-gener-
ation cancer treatment. Robins &
deputy director of Miami Cancer Institute. Morton served as the concrete sub-
contractor to Gilbane Building
Company on the Proton Therapy
Building, which will house the
cyclotron. Robins & Morton was
responsible for the concrete structure
surrounding the proton treatment
vaults and equipment. The construc-
tion of the vaults included 15,000 cubic yards of specialized radiation shielding mass
concrete and required a great deal of coordination due to its location within the
Miami Cancer Institute complex. The two firms, Gilbane and Robins & Morton,
worked together to develop a partnering approach ensuring the project runs smoothly
and meets Baptist Health South Florida’s needs.

In addition to the Proton Therapy Building, Robins & Morton is completing the
305,000 square foot Miami Cancer Institute at Baptist Health South Florida.

Miami Cancer Institute at Baptist in the fight against cancer.” Local Cardiologist Chosen to
Health South Florida has wel- “This is the most cutting-edge proton Conduct Heart Valve Research for
comed the future of cancer care Treatment of Severe Aortic Stenosis
with the arrival of its 220-ton proton therapy technology available,” said
therapy cyclotron. Minesh Mehta, M.D., deputy director of Two of Tenet Florida Heart &
the Miami Cancer Institute and chief of Vascular Network’s top heart
As the cornerstone of the only proton radiation oncology. “It uses a pencil- experts, Dr. Brian Bethea,
therapy center in South Florida, the beam approach, allowing us to target Regional Medical Director of
cyclotron’s arrival ensures that patients more complicated tumors and, for most
in the region and across Latin America situations, further decreases radiation Cardiovascular Surgery, and Dr.
and the Caribbean no longer will need to exposure to normal tissues in compari-
travel far from home to access the treat- son to older proton techniques. That Brijeshwar Maini, Regional
ment. The technology will offer pencil means that there is significantly less
beam scanning – the most precise form damage to healthy tissue, a decrease in Medical Director of Transcatheter
of proton radiation treatment. Proton side effects and less chance of a recur-
therapy destroys cancer cells with high- rence of cancer due to radiation expo- Therapies, are researching a heart
ly-targeted doses of radiation while sure.”
avoiding healthy tissue and minimizing valve system for patients with
side effects, making it particularly effec- In March 2015, Baptist Health South
tive in treating childhood cancers and Florida signed an agreement with IBA, severe aortic stenosis, the most
adult cancers of the brain, liver and lung, the world’s leading provider of proton
as well as certain left-sided breast can- therapy solutions for the treatment of common and serious heart valve
cers and prostate cancers. Proton thera- cancer.
py treatment will be available at Miami disease. Dr. Bethea and Dr. Maini Dr. Brian Bethea Dr. Brijeshwar Maini
Cancer Institute beginning in 2017. “We are very pleased that Miami are co-primary investigators in the
Cancer Institute selected IBA as their
“The arrival of the cyclotron signifies partner to bring the most advanced pro- Lotus™ Valve System REPRISE III
the beginning of the most sophisticated ton therapy to their patients in South
cancer treatment technology in the his- Florida as well as the Latin America clinical trial. As a team, Dr. Bethea and Dr. Maini will study and evaluate the safety
tory of our organization,” said Brian E. region,” said Beth Klein, president of IBA
Keeley, president and CEO of Baptist PT North America. “Our 30-plus years of and effectiveness of this new heart valve system in patients with severe aortic stenosis.
Health South Florida. “This historic experience elicits confidence in our abil-
milestone is not just one for Baptist ity to support the swift construction and These patients are considered high or extreme risk for heart valve replacement sur-
Health to celebrate, but one for our installation of this equipment, which
entire community as we come together means providing faster access to the gery.
technology for their patients.”
The benefits of the Lotusâ„¢ Valve System as the first transcatheter aortic valve

replacement (TAVR) device both fully repositionable and retrievable prior to release,

will be studied by the clinical research team.

Specialized Nursing Services celebrating 20 years covering Dade and Broward counties.

• We are focused on reducing • Our goal is for the patient to • Our Patient Advocates begin to
re-admissions to the hospital by live safely and independently for a establish a long-term relationship at
implementing our Transitional lifetime. the point of admissions with the
Care Program. patient.

To speak to a Patient Advocate, please call: Broward: 954-835-4400 • Dade: 305-652-2799 • www.SNSnursing.com

South Florida Hospital News southfloridahospitalnews.com July 2016 27